Contained Criminal Case

The most likely outcome is that prosecutors treat the matter as a discrete counterfeit-drug trafficking case rather than evidence of a systemic U.S. GLP-1 market failure. DOJ, FDA Office of Criminal Investigations, and Homeland Security Investigations use the indictment to deter copycat importers while Novo Nordisk continues separate civil and anti-counterfeiting efforts.

Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.